Allogeneic Transplantation for Patients with Advanced Acute Leukemia: a Single Center Retrospective Study of 92 Patients

References

• Biggs J. C., Horowitz M. M., Gale R. P., Ash R. C., Atkinson K., Helbig W., Jacobsen N., Phillips G. L., Rimm A. A., Ringden O. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992; 80: 1090–1093
   PubMed Web of Science ®Google Scholar
• Forman S. J., Schmidt G. M., Nademanee A. P., Amylon M. D., Chao N. J., Fahey J. L., Konrad P. N., Margolin K. A., Niland J. C., O'Donnell M. R. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. Journal of Clinical Oncology 1991; 9: 1570–1574
   PubMed Web of Science ®Google Scholar
• Mehta J., Powles R., Morton C., Milan S., Treleaven J., Tait D., Catovsky D. Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplantation 1994; 14: 415–418
   PubMed Web of Science ®Google Scholar
• Henslee-Downey P. J., Abhyankar S. H., Parrish R. S., Pati A. R., Godder K. T., Neglia W. J., Goon-Johnson K. S., Geier S. S., Lee C. G., Gee A. P. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864–3872
   PubMed Web of Science ®Google Scholar
• Russell J. A., Desai S., Herbut B., Brown C., Luider J., Ruether J. D., Stewart D., Chaudhry A., Booth K., Jorgenson K., Coppes M. J., Turner A. R., Larratt L., Poon M. C., Klassen J. Partially mismatched blood cell transplants for high-risk hematologic malignancy. Bone Marrow Transplantation 1997; 19: 861–866
   PubMed Web of Science ®Google Scholar
• Beelen D. W., Ottinger H. D., Elmaagacli A., Scheulen B., Basu O., Kremens B., Havers W., Grosse-Wilde H., Schaefer U. W. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematological malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 1997; 90: 4725–4735
   PubMed Web of Science ®Google Scholar
• Greinix H. T., Reiter E., Keil F., Fischer G., Lechner K., Dieckmann K., Leitner G., Schulenburg A., Hoecker P., Haas O. A., Knoebl P., Mannhalter C., Fonatsch C., Hinterberger W., Kalhs P. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and related donors. Bone Marrow Transplantation 1998; 21: 673–678
   PubMed Web of Science ®Google Scholar
• Davies S. M., Shu X. O., Blazar B. R., Filipovich A. H., Kersey J. H., Krivit W., McCullough J., Miller W. J., Ramsay N. K., Segall M. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995; 86: 1636–1642
   PubMed Web of Science ®Google Scholar
• Nademanee A., Schmidt G. M., Parker P., Dagis A. C., Stein A., Snyder D. S., O'Donnell M., Smith E. P., Stepan D. E., Molina A. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 1995; 86: 1228–1234
   PubMed Web of Science ®Google Scholar
• Blaise D., Olive D., Michallet M., Marit G., Leblond V., Maraninchi D. Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis. Lancet 1995; 345: 1144–1146
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Non-parametric estimation from incomplete observations. Journal of the American Statistics Assocation 1958; 53: 457–481
   Web of Science ®Google Scholar
• Petersdorf E. W., Longton G. M., Anasetti C., Martin P. J., Mickelson E. M., Smith A. G., Hansen J. A. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606–1613
   PubMed Web of Science ®Google Scholar
• Oudshoorn M., Cornelissen J. J., Fibbe W. E., de Graeff-Meeder E. R., Lie J. L., Schreuder G. M., Sintnicolaas K., Willemze R., Vossen J. M., van Rood J. J. Problems and possible solutions in finding un unrelated bone marrow donor. Results of consecutive searches for 240 dutch patients. Bone Marrow Transplantion 1997; 20: 1011–1017
   PubMed Web of Science ®Google Scholar
• Lamparelli T., Van Lint M. T., Gualandi F., Occhini D., Barbanti M., Sacchi N., Ficai G., Ghinatti C., Ferrara G. B., Delfino L., Pozzi S., Morabito A., Zikos P., Vitale V., Corvo R., Frassoni F., Bacigalupo A. Bone marrow transplantation for chronic myeloid leukemia from unrelated and sibling donors single center experience. Bone Marrow Transplantation 1997; 20: 1057–1062
   PubMed Web of Science ®Google Scholar
• Sasazuki T., Juji T., Morishima Y., Kinukawa N., Kashiwabara H., Inoko H., Yoshida T., Kimura A., Akaza T., Kamikawaji N., Kodera Y., Takaku R. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. New England Journal of Medicine 1998; 339: 1177–1185
   PubMed Web of Science ®Google Scholar
• Sierra J., Storer B., Hansen J. A., Bjerke J. W., Martin P. J., Petersdorf E. W., Appelbaum F. R., Bryant E., Chauncey T. R., Sale G., Sanders J. E., Storb R., Sullivan K. M., Anasetti C. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226–4235
   PubMed Web of Science ®Google Scholar
• Busca A., Anasetti C., Anderson G., Appelbaum F. R., Buckner C. D., Doney K., Martin P. J., Petersdorf E., Sanders J. E., Hansen J. A. Unrelated donor or pautologous marrow transplantation for treatment of acute leukemia. Blood 1994; 83: 3077–3084
   PubMed Web of Science ®Google Scholar
• Szydlo R., Goldman J. M., Klein J. P., Gale R. P., Ash R. C., Bach F. H., Bradley B. A., Casper J. T., Flomenberg N., Gajewski J. L., Gluckman E., Henslee-Downey P. J., Hows J. M., Jacobsen N., Kolb H. J., Lowenberg B., Masaoka T., Rowlings P. A., Sondel P. M., van Bekkum D. W., van Rood J. J., Vowels M. R., Zhang M. J., Horowitz M. M. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Journal of Clinical Oncology 1997; 5: 1767–1777
   Google Scholar
• Michallet M., Vernant J. -P., Espérou-Bourdeau H., Milpied N., Blaise D., Rio B., Jouet J. -P., Bourhis J. -H., Lioure B., Reiffers J., Tanguy M. -L., Belhabri A., Archimbaud E. Place of allogeneic bone marrow transplant (BMT) for primary resistant or relapsed acute myeloblastic leukemia (AML) a study of 424 patients from the Société Française de Greffe de Moelle registry. Blood 1998; 92(suppl 1)a2717
   Google Scholar
• Aversa F., Tabilio A., Velardi A., Cunningham I., Terenzi A., Falzetti F., Ruggeri L., Barbabietola G., Aristei C., Latini P., Reisner Y., Martelli M. R. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype. New England Journal of Medicine 1998; 339: 1186–1193
   PubMed Web of Science ®Google Scholar
• Pikkemaat F., De Witte T., Van Biezen A., Hermans J., MacKinnon S., Cornelissen J., Gratwohl A., Boogaerts M., Iriondo A., Kuentz M., Harousseau J. -L., Fauser A., Wandt H., Niederweiser D., Apperley J. Transplantation with genotypically nonidentical donors for myelodysplastic syndrome and secondary acute myeloid leukemia. An analysis by the MDS study group of the EBMT chronic leukemia working party. Bone Marrow Transplantation 1999; 23(suppl 1)a503
   Google Scholar
• Attal M., Huguet F., Rubie H., Huynh A., Charlet J. P., Payen J. L., Voigt J. J., Brousset P., Selves J., Muller C., Pris J., Laurent G. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin a prospective, randomized trial. Blood 1992; 79: 2834–2840
   PubMed Web of Science ®Google Scholar
• Ohashi K., Tanabe J., Watanabe R., Sakamaki H., Maruta A., Okamoto S., Aotuka N., Saito K., Nishimura M., Oh H., Matuzaki M., Takahashi S., Yonekura S. The Japanese multicenter open randomized trial of prophylactic ursodeoxychilic acid for veno-occlusive disease of the liver in patients undergoing stem cell transplantation. Blood 1998; 92(suppl 1)A1131
   PubMedGoogle Scholar
• Abraham R., Szer J., Bardy P., Grigg A. Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants. Bone Marrow Transplantation 1997; 20: 773–777
   PubMed Web of Science ®Google Scholar